Premium
A majority of parents of children with peanut allergy fear using the epinephrine auto‐injector
Author(s) -
Chad L.,
BenShoshan M.,
Asai Y.,
Cherkaoui S.,
Alizadehfar R.,
StPierre Y.,
Harada L.,
Allen M.,
Clarke A.
Publication year - 2013
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.12262
Subject(s) - peanut allergy , anaphylaxis , epinephrine , allergy , medicine , food allergy , pediatrics , allergic reaction , family medicine , immunology , anesthesia
Prompt epinephrine administration is crucial in managing anaphylaxis, but epinephrine auto‐injectors ( EAIs ) are underutilized by patients and their families. Children with peanut allergy were recruited from the A llergy C linics at the M ontreal C hildren's H ospital, food allergy advocacy organizations and organizations providing products to allergic individuals. Parents of children who had been prescribed an EAI were queried on whether they were fearful of using it and on factors that may contribute to fear. A majority of parents (672/1209 = 56%) expressed fear regarding the use of the EAI . Parents attributed the fear to hurting the child, using the EAI incorrectly or a bad outcome. Parents whose child had longer disease duration or a severe reaction and parents who were satisfied with the EAI training or found it easy to use were less likely to be afraid. Families may benefit from simulation training and more education on the recognition and management of anaphylaxis.